Investors

In this section of the Rock Creek Pharmaceuticals Investor pages, you'll find our news releases. The releases are listed in chronological order and are archived by year.

Archives: Search / 2016 / 2015 / 2014

Aug 11, 2016

Rock Creek Pharmaceuticals, Inc., (OTCQB: RCPI), a clinical-stage drug development company focused on the application of its lead compound to treat acute and chronic inflammatory conditions, filed...

More
Jul 8, 2016

Rock Creek Pharmaceuticals, Inc., (OTCQB: RCPI), a clinical-stage drug development company focused on the application of its lead compound to treat acute and chronic inflammatory conditions,...

More
Jun 1, 2016

Rock Creek Pharmaceuticals, Inc., (OTCQB: RCPI), a clinical-stage drug development company focused on the application of its lead compound to treat acute and chronic inflammatory conditions,...

More
May 16, 2016

Rock Creek Pharmaceuticals, Inc., (OTCQB: RCPI), a clinical-stage drug development company focused on the application of its lead compound to treat acute and chronic inflammatory conditions, today...

More
May 5, 2016

Rock Creek Pharmaceuticals, Inc., (OTCQB: RCPI), a clinical-stage drug development company focused on the application of its lead compound to treat acute and chronic inflammatory conditions,...

More
 

print email rss